Investigation of a Prostate Cancer Radiation Response Signature in the Breast Cancer SweBCG91RT Randomized Trial
Shuang G. Zhao, Erik Holmberg, Dan Lundstedt, Fredrika Killander et autres
0 citationsClinical Cancer Research
Dan Lundstedt
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
121Publications signalées
2284Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesBreast Cancer Treatment StudiesMonoclonal and Polyclonal Antibodies ResearchFerroptosis and cancer prognosis
Publications récentes
Omission of completion axillary dissection in patients with breast cancer and sentinel lymph node macrometastases: Overall survival and patient-reported arm morbidity from the randomized SENOMAC trial.
J de Boniface, T Filtenborg Tvedskov, L Ryden, Robert Szulkin et autres
2 citationsJournal of Clinical Oncology
Association between shoulder joint radiation dose and arm morbidity in the randomized breast cancer trial SENOMAC
Sara Alkner, Matilda Appelgren, Robert Szulkin, Elinore Wieslander et autres
1 citationRadiotherapy and Oncology
Supplementary Figure S1 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
Axel Stenmark Tullberg, Martin Sjöström, Emma Niméus, Fredrika Killander et autres
0 citations
Supplementary Figure S5 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
Axel Stenmark Tullberg, Martin Sjöström, Emma Niméus, Fredrika Killander et autres
0 citations
Supplementary Figure S4 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
Axel Stenmark Tullberg, Martin Sjöström, Emma Niméus, Fredrika Killander et autres
0 citations
Supplementary Figure S3 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
Axel Stenmark Tullberg, Martin Sjöström, Emma Niméus, Fredrika Killander et autres
0 citations
Supplementary Tables S5-S11 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
Axel Stenmark Tullberg, Martin Sjöström, Emma Niméus, Fredrika Killander et autres
0 citations
Supplementary Tables S1-S4 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
Axel Stenmark Tullberg, Martin Sjöström, Emma Niméus, Fredrika Killander et autres
0 citations
Supplementary Figure S2 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
Axel Stenmark Tullberg, Martin Sjöström, Emma Niméus, Fredrika Killander et autres
0 citations
Study protocol S1 from Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial
Axel Stenmark Tullberg, Martin Sjöström, Emma Niméus, Fredrika Killander et autres
0 citations
Axillary clearance and chemotherapy rates in ER+HER2− breast cancer: secondary analysis of the SENOMAC trial
Tove Filtenborg Tvedskov, Robert Szulkin, Sara Alkner, Yvette Andersson et autres
3 citationsThe Lancet Regional Health - Europe
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.